反应性疫苗接种作为非洲脑膜炎带肺炎球菌脑膜炎暴发控制策略:基于加纳暴发数据的分析
研究利用加纳布朗-阿哈福地区五个月周线列表数据,将既往脑膜炎球菌暴发反应性疫苗接种模型适配于肺炎球菌脑膜炎暴发,评估不同流行阈值敏感性与特异性,并估算反应性接种可避免的病例和死亡。每10万人每周10例疑似病例阈值表现最佳,预测大暴发的敏感性100%、特异性超过85%。本次暴发中反应性接种每避免1例约需接种15300剂,高于既往脑膜炎球菌暴发的估算,但鉴于肺炎球菌脑膜炎死亡和残疾负担更高,考虑反应性接种仍可能有价值。
要点
- 每10万人每周10例疑似病例的流行阈值预测大暴发敏感性100%、特异性超过85%。
- 本次暴发中反应性接种每避免1例约需接种15300剂,高于既往脑膜炎球菌暴发估算。
- 肺炎球菌脑膜炎死亡和残疾负担高于脑膜炎球菌脑膜炎,考虑反应性接种仍可能有价值。
核心结论
- 在本次肺炎球菌脑膜炎暴发中,反应性接种每避免1例约需接种15300剂,高于既往脑膜炎球菌暴发的估算,但鉴于肺炎球菌脑膜炎死亡和残疾负担更高,考虑反应性接种仍可能有价值。
- 需要更多暴发数据来完善模型估算,并强调无论采取何种政策,及时实验室确诊疑似病例对做出恰当暴发应对决策至关重要。
研究设计与样本
- 研究将既往脑膜炎球菌暴发反应性疫苗接种模型适配于加纳中部布朗-阿哈福地区近期一次肺炎球菌脑膜炎暴发。
- 分析使用五个月期间所有疑似病例的周线列表数据,确定不同流行阈值的敏感性和特异性,并模拟反应性接种可避免的病例和死亡。
主要发现
- 每10万人每周10例疑似病例的流行阈值表现最佳,预测大暴发敏感性100%、特异性超过85%。
- 本次暴发中反应性接种每避免1例约需接种15300剂,高于既往脑膜炎球菌暴发的估算。
关键数值与推荐
- 流行阈值定为每10万人每周10例疑似病例时,预测大暴发敏感性100%、特异性超过85%。
- 本次暴发中反应性接种约每15300剂可避免1例病例。
临床怎么用
- 原文未据此给出推荐。
- 作者认为,鉴于肺炎球菌脑膜炎死亡和残疾负担高于脑膜炎球菌脑膜炎,考虑反应性接种仍可能有价值。
- 作者强调无论采取何种政策,及时实验室确诊疑似病例对做出恰当暴发应对决策至关重要。
局限性
- 需要更多暴发数据来完善模型估算。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Streptococcus pneumoniae is increasingly recognised as an important cause of bacterial meningitis in the African meningitis belt. The World Health Organization sets guidelines for response to outbreaks of meningococcal meningitis, but there are no current guidelines for outbreaks where S. pneumoniae is implicated. We aimed to evaluate the impact of using a similar response to target outbreaks of vaccine-preventable pneumococcal meningitis in the meningitis belt. Here, we adapt a previous model of reactive vaccination for meningococcal outbreaks to estimate the potential impact of reactive vaccination in a recent pneumococcal meningitis outbreak in the Brong-Ahafo region of central Ghana using weekly line list data on all suspected cases over a period of five months. We determine the sensitivity and specificity of various epidemic thresholds and model the cases and deaths averted by reactive vaccination. An epidemic threshold of 10 suspected cases per 100,000 population per week performed the best, predicting large outbreaks with 100% sensitivity and more than 85% specificity. In this outbreak, reactive vaccination would have prevented a lower number of cases per individual vaccinated (approximately 15,300 doses per case averted) than previously estimated for meningococcal outbreaks. Since the burden of death and disability from pneumococcal meningitis is higher than that from meningococcal meningitis, there may still be merit in considering reactive vaccination for outbreaks of pneumococcal meningitis. More outbreak data are needed to refine our model estimates. Whatever policy is followed, we emphasize the importance of timely laboratory confirmation of suspected cases to enable appropriate decisions about outbreak response.
引用
- Cooper LV, Stuart JM, Okot C, et al. Reactive vaccination as a control strategy for pneumococcal meningitis outbreaks in the African meningitis belt: Analysis of outbreak data from Ghana. Vaccine. 2018. PMID: 29371015. doi:10.1016/j.vaccine.2017.12.069
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。